Transaction #29492 · Form 4 · 0001222676-26-000012
ZIMMER BIOMET HOLDINGS, INC. · Stock award · Phantom Stock Units
ZIMMER BIOMET HOLDINGS, INC. · Transacted September 30, 2026 · Filed October 2, 2026
What does this filing report?
An SEC Form 4 filing for ZIMMER BIOMET HOLDINGS, INC. records a stock award involving Phantom Stock Units on September 30, 2026. The reported quantity was 306.066. The filing date is October 2, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- ZIMMER BIOMET HOLDINGS, INC.
- Company CIK
- 0001136869
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 306.066
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 33,660.84
- Ownership description
- Not reported
- SEC acceptance time
- Oct 2, 2026, 4:21 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- HAGEMANN ROBERT ↗
Director
CIK 0001222676
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 306.066
- Conversion / exercise price
- 89.85
- Exercise date
- Not reported
- Expiration date
- Not reported
Filing footnotes & remarks
- F1
- The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
- F2
- The Conversion or Exercise Price of Derivative Security is 1-for-1.
- F3
- Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
- F4
- Includes 85.331 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.